Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson’s activity

Author： Gluck M. R.   Santana L. A.   Granson H.   Yahr M. D.  

Publisher： Springer Publishing Company

ISSN： 0300-9564

Source： Journal of Neural Transmission, Vol.111, Iss.6, 2004-06, pp. : 713-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-Narcoleptic Agent Modafinil and Its Sulfone: A Novel Facile Synthesis and Potential Anti-Epileptic Activity

By Chatterjie Nithiananda   Stables James P.   Wang Hsin   Alexander George J.  

Neurochemical Research, Vol. 29, Iss. 8, 2004-08 ,pp. : 1481-1486

Springer Publishing Company

Access to resources Recommend Favorite

Can anti-inflammatory agents protect against Parkinson’’s disease?

By Ritz Beate   Wahner Angelika D   Bordelon Yvette   Bronstein Jeff M  

Future Neurology, Vol. 3, Iss. 2, 2008-03 ,pp. : 107-111

Future Medicine

Access to resources Recommend Favorite

A Novel Anti-Parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice

By Yano Ryohei  

Journal of Molecular Neuroscience, Vol. 39, Iss. 1-2, 2009-09 ,pp. : 211-219

Humana Press, Inc

Access to resources Recommend Favorite

A Novel Anti-Parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice

By Yano Ryohei  

Journal of Molecular Neuroscience, Vol. 39, Iss. 1-2, 2009-09 ,pp. : 320-320

Humana Press, Inc

Access to resources Recommend Favorite

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite